ProfileGDS5822 / ILMN_2640560
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 56% 4% 7% 6% 20% 4% 9% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 12556
GSM1276600PDAC Late Ablation Control 29.24
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 187
GSM1276603PDAC Late Ablation 26.86
GSM1276604PDAC Late Ablation 311.920
GSM1303940PDAC Late Ablation_anti-CTLA4 16.54
GSM1303941PDAC Late Ablation_anti-CTLA4 26.69
GSM1303942PDAC Late Ablation_anti-CTLA4 3